REKAH Fundamentals

REKAH PHARMA IND fundamentals help investors to digest information that contributes to REKAH PHARMA's financial success or failures. It also enables traders to predict the movement of REKAH Stock. This fundamental analysis module provides a way for investors to measures REKAH PHARMA's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to REKAH PHARMA stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

REKAH Fundamentals 

 
Refresh

REKAH Net Income Analysis

REKAH PHARMA's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Net Income 
 = 
(Rev + Gain) 
-  
(Exp + Loss) 
More About Net Income | All Equity Analysis

Current REKAH PHARMA Net Income

    
  5.37 M  
Most of REKAH PHARMA's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, REKAH PHARMA IND is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Compare to competition

Based on the recorded statements, REKAH PHARMA IND reported net income of 5.37 M. This is 98.43% lower than that of the Healthcare sector and 101.39% lower than that of the Drug Manufacturers - Specialty & Generic industry. The net income for all Israel stocks is 99.06% higher than that of the company.

REKAH PHARMA IND Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining REKAH PHARMA's current stock value. Our valuation model uses many indicators to compare REKAH PHARMA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across REKAH PHARMA competition to find correlations between indicators driving REKAH PHARMA's intrinsic value. More Info.
REKAH PHARMA IND is currently regarded number one company in revenue category among related companies. It is currently regarded as top stock in price to sales category among related companies . The ratio of Revenue to Price to Sales for REKAH PHARMA IND is about  1,564,437 

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

REKAH Fundamentals

REKAH PHARMA Investors Sentiment

The influence of REKAH PHARMA's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in REKAH. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - REKA

REKAH PHARMA IND Investor Sentiment

Macroaxis portfolio users are evenly split in their perspective on investing in REKAH PHARMA IND. What is your perspective on investing in REKAH PHARMA IND? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Currently Active Assets on Macroaxis

Check out Your Equity Center. Note that the REKAH PHARMA IND information on this page should be used as a complementary analysis to other REKAH PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Tools for REKAH Stock

When running REKAH PHARMA IND price analysis, check to measure REKAH PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy REKAH PHARMA is operating at the current time. Most of REKAH PHARMA's value examination focuses on studying past and present price action to predict the probability of REKAH PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move REKAH PHARMA's price. Additionally, you may evaluate how the addition of REKAH PHARMA to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go